Autism spectrum disorder has often been assumed to be a protective factor against substance use, yet the extent of substance use in this population has been difficult to determine as limited research has been done on these interacting variables. This systematic literature review examined 26 studies published between 2009 and 2019 to uncover the relationship between autism spectrum disorder and substance use. The types of participants included from the primary studies are adults and adolescents. A significant indication that this population is more susceptible to substance use and related disorders was found, yet this may only remain true for adults. Various interacting environmental and genetic/neurological factors combine and may contribute towards this vulnerability such as feelings of isolation, deficits in executive functioning and genetic heritability. High comorbidity rates of depression, anxiety disorders and attention deficit/hyperactivity disorder may further strengthen this vulnerability. Screening for substance use in these patients is not a common practice and the treatment of substance use disorder remains a challenge suggesting that many individuals may remain underdiagnosed. This research paper thus demonstrates the need and importance of more primary research to be done and for greater awareness of this vulnerability within mental health settings.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Arnevik, E. A., & Helverschou, S. B. (2016). Autism spectrum disorder and co-occurring substance use disorder - a systematic review. Substance abuse: research and treatment, 10, 69–75. https://doi.org/10.4137/SART.S39921.
Butwicka, A., Langstrom, N., Larsson, H., Lundstrom, S., Serlachius, E., Almqvist, C., Frisen, L., & Lichtenstein, P. (2017). Increased risk for substance use-related problems in autism spectrum disorders: A population-based cohort study. Journal of Autism and Developmental Disorders, 47(1), 80–89. https://doi.org/10.1007/s10803-016-2914-2.
Casartelli, L., & Chiamulera, C. (2016). The motor way: Clinical implications of understanding and shaping actions with the motor system in autism and drug addiction. Cognitive, Affective, & Behavioral Neuroscience, 16(2), 191–206. https://doi.org/10.3758/s13415-015-0399-7.
Cascio, R. S., & Kilmon, C. A. (1997). Pervasive developmental disorder not otherwise specified: primary care perspectives. The Nurse Practitioner, 22(7), 11–15 Retrieved from: https://journals.lww.com/tnpj/Abstract/1997/07000/Pervasive_Developmental_Disorder,_Not_Otherwise.2.aspx.
Churchard, A., Ryder, M., Greenhill, A., & Mandy, W. (2019). The prevalence of autistic traits in a homeless population. Autism: The International Journal of Research and Practice, 23(3), 665–676. https://doi.org/10.1177/1362361318768484.
Craig, F., Margari, F., Legrottaglie, A. R., Palumbi, R., de Giambattista, C., & Margari, L. (2016). A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatric disease and treatment, 12, 1191–1202. Retrieved from: doi:https://doi.org/10.2147/NDT.S104620
Curtis, A. C. (2015). Defining adolescence. Journal of Adolescent and Family Health, 7(2), 1–4 Retrieved from: http://scholar.utc.edu/jafh/vol7/iss2/2.
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., et al. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology, 235(11), 3137–3148. https://doi.org/10.1007/s00213-018-5010-9.
Dang, W., Zhang, Q., Zhu, Y., & Lu, X. (2014). The evidence for the contribution of the autism susceptibility candidate 2 (AUTS2) gene in heroin dependence susceptibility. Journal of Molecular Neuroscience, 54(4), 811–819. https://doi.org/10.1007/s12031-014-0421-5.
De Alwis, D., Agrawal, A., Reiersen, A. M., Constantino, J. N., Henders, A., Martin, N. G., & Lynskey, M. T. (2014). ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins. Journal of Studies on Alcohol and Drugs, 75(2), 211-221. https://doi.org/10.15288/jsad.2014.75.211
Helverschou, S. B., Brunvold, A. R., & Arnevik, E. A. (2019). Treating patients with co-occurring autism spectrum disorder and substance use disorder: A clinical explorative study. Substance Abuse: Research and Treatment, 13, 1–10. https://doi.org/10.1177/1178221819843291.
Hofvander, B., Delorme, R., Chaste, P., Nyden, A., Wentz, E., Stahlberg, O., Herbrecht, E., Stopin, A., Anckarsater, H., Gillberg, C., Rastam, M., & Leboyer, M. (2009). Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry, 9(1), 1-9. Retrieved from. https://doi.org/10.1186/1471-244X-9-35oi.org/10.1186/1471-244X-9-35.
Janik, P., Kosticova, M., Pecenak, J., & Turcek, M. (2017). Categorization of psychoactive substances into “hard drugs” and “soft drugs”: A critical review of terminology used in current scientific literature. The American Journal of Drug and Alcohol Abuse, 43(6), 636–646. https://doi.org/10.1080/00952990.2017.1335736.
Joshi, G., Wozniak, J., Petty, C., Martelon, M. K., Fried, R., Bolfek, A., et al. (2013). Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. Journal of Autism and Developmental Disorders, 43(6), 1314–1325. https://doi.org/10.1007/s10803-012-1679-5.
Kreiser, N., & White, S. (2015). ASD traits and co-occurring psychopathology: The moderating role of gender. Journal of Autism and Developmental Disorders, 45(12), 3932–3938. https://doi.org/10.1007/s10803-015-2580-9.
Kronenberg, L. M., Slager-Visscher, K., Goossens, P. J. J., & Brink, W. v. d., & Achterberg, T. v. (2014). Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): A patient's perspective. BMC Psychiatry, 14, 1–9. https://doi.org/10.1186/s12888-014-0264-1.
Kronenberg, L. M., Goossens, P. J. J., & Etten, D. M. v., Achterberg, T. v., & Brink, W. v. d. (2015a). Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Perspectives in Psychiatric Care, 51, 4–15. https://doi.org/10.1111/ppc.12056.
Kronenberg, L. M., Goossens, P. J. J., van Busschbach, J., van Achterberg, T., & van den Brink, W. (2015b). Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). BMC Psychiatry, 15(1), 1–8. https://doi.org/10.1186/s12888-015-0530-x.
Kronenberg, L. M., Goossens, P. J. J., van Busschbach, J. T., van Achterberg, T., & van den Brink, W. (2016). Burden and expressed emotion of caregivers in cases of adult substance use disorder with and without attention deficit/hyperactivity disorder or autism spectrum disorder. International Journal of Mental Health and Addiction, 14(1), 49–63. https://doi.org/10.1007/s11469-015-9567-9.
Lake, J., & Turner, M. S. (2017). Urgent need for improved mental health care and a more collaborative model of care. The Permanente Journal, 21, 17–24. https://doi.org/10.7812/TPP/17-024.
Lalanne, L., Weiner, L., Trojak, B., Berna, F., & Bertschy, G. (2015). Substance-use disorder in high-functioning autism: Clinical and neurocognitive insights from two case reports. BMC Psychiatry, 15, 1–5. https://doi.org/10.1186/s12888-015-0541-7.
Lalanne, L., Weiner, L., & Bertschy, G. (2017). Treatment of addiction in adults with autism spectrum disorder. In J. Matson, Handbook of Treatments for Autism Spectrum Disorder (1st ed., pp. 377-395). Springer International Publishing. https://doi.org/10.1007/978-3-319-61738-1
Långström, N., Grann, M., Ruchkin, V., Sjöstedt, G., & Fazel, S. (2009). Risk factors for violent offending in autism spectrum disorder. Journal of Interpersonal Violence, 24(8), 1358–1370. https://doi.org/10.1177/0886260508322195.
Lever, A., & Geurts, H. (2016). Psychiatric co-occurring symptoms and disorders in young, middle-aged, and older adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 46(6), 1916-1930. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26861713
Lundstrom, S., Chang, Z., Kerekes, N., Gumpert, C. H., Rastam, M., Gillberg, C., Lichtenstein, P., & Anckarsater, H. (2011). Autistic-like traits and their association with mental health problems in two nationwide twin cohorts of children and adults. Psychological Medicine, 41(11), 2423–2433. https://doi.org/10.1017/S0033291711000377.
Maenner, M. J., Rice, C. E., Arneson, C. L., Cunniff, C., Schieve, L. A., Carpenter, L. A., et al. (2014). Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates. JAMA psychiatry, 71(3), 292–300. https://doi.org/10.1001/jamapsychiatry.2013.3893.
Mangerud, W. L., Bjerkeset, O., Holmen, T. L., Lydersen, S., & Indredavik, M. S. (2014). Smoking, alcohol consumption, and drug use among adolescents with psychiatric disorders compared with a population-based sample. Journal of Adolescence, 37(7), 1189–1199. https://doi.org/10.1016/j.adolescence.2014.08.007.
McLellan, A. T. (2017). Substance misuse and substance use disorders: Why do they matter in healthcare? Transactions of the American Clinical and Climatological Association, 128, 112–130 Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525418/.
Mulligan, R. C., Reiersen, A. M., & Todorov, A. A. (2014). Attention-deficit/hyperactivity disorder, autistic traits, and substance use among Missouri adolescents. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, 2(2), 86–92 Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489415/.
National Library of Medicine (U.S.). (2019, March -). A phase 2 study of cannabidiol as a new treatment for autism spectrum disorder in children and adolescents. Identifier: NCT03900923. https://clinicaltrials.gov/ct2/show/NCT03900923.
Ortiz-Medina, M. B., Grau-López, L., Arce Ramírez, A., Torales Benítez, J. C., & Roncero, C. (2014). Comorbidity between autism spectrum disorders and substance use disorders. Presented at the XVI World Congress of Psychiatry, Madrid, Spain. https://doi.org/10.13140/RG.2.1.4319.0000.
Palmqvist, M., Edman, G., & Bölte, S. (2014). Screening for substance use disorders in neurodevelopmental disorders: A clinical routine? European Child & Adolescent Psychiatry, 23(5), 365–368. https://doi.org/10.1007/s00787-013-0459-x.
Ramos, M., Boada, L., Moreno, C., Llorente, C., Romo, J., & Parellada, M. (2013). Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome. Drug and alcohol dependence, 133(2), 535–540. https://doi.org/10.1016/j.drugalcdep.2013.07.022.
Rengit, A. C., McKowen, J. W., O'Brien, J., Howe, Y. J., & McDougle, C. J. (2016). Brief report: Autism spectrum disorder and substance use disorder: A review and case study. Journal of Autism and Developmental Disorders, 46(7), 2514–2519. https://doi.org/10.1007/s10803-016-2763-z.
Schapir, L., Lahav, T., Zalsman, G., Krivoy, A., Sever, J., Weizman, A., & Shoval, G. (2016). Cigarette smoking, alcohol and cannabis use in patients with pervasive developmental disorders. Substance use & Misuse, 51(11), 1415–1420. https://doi.org/10.3109/10826084.2016.1170146.
Sizoo, B., van den Brink, W., Gorissen-van Eenige, M., & van der Gaag, R. J. (2009a). Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders. The Journal of Nervous and Mental Disease, 197(6), 450–454. https://doi.org/10.1097/NMD.0b013e3181a61dd0.
Sizoo, B., van den Brink, W., Gorissen-van Eenige, M., Koeter, M. W., van Wijngaarden-Cremers, P., & van der Gaag, R. J. (2009b). Using the autism-spectrum quotient to discriminate autism spectrum disorder from ADHD in adult patients with and without comorbid substance use disorder. Journal of Autism and Developmental Disorders, 39(9), 1291–1297. https://doi.org/10.1007/s10803-009-0743-2.
Sizoo, B., van den Brink, W., Franke, B., Vasquez, A. A., van Wijngaarden-Cremers, P., & van der Gaag, R. J. (2010a). Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders? World Journal of Biological Psychiatry, 11(5), 699–708. https://doi.org/10.3109/15622975.2010.480985.
Sizoo, B., van den Brink, W., Koeter, M., van Eenige, M. G., van Wijngaarden-Cremers, P., & van der Gaag, R. J. (2010b). Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. Drug and alcohol dependence, 107(1), 44–50. https://doi.org/10.1016/j.drugalcdep.2009.09.003.
Van Wijngaarden-Cremers, P. J. M., Brink, W. V., & Gaag, R. J. (2014). Addiction and autism: A remarkable comorbidity. Journal of Alcoholism and Drug Dependence, 2(4), 170. https://doi.org/10.1007/978-3-642-45375-5_14.
Conflict of Interest
The authors declare that there is no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Haasbroek, H., Morojele, N. A Systematic Literature Review on the Relationship Between Autism Spectrum Disorder and Substance Use Among Adults and Adolescents. Rev J Autism Dev Disord (2021). https://doi.org/10.1007/s40489-021-00242-1
- Autism spectrum disorder (ASD)
- Neurodevelopmental disorders
- Substance use
- Substance use disorder (SUD)
- Systematic literature review